查看购物车
  • Traditional Chinese
  • English
  • Japanese
  • Korean
封面
市场调查报告书
商品编码
1439386

矫形手指植入物 - 全球市场回顾、竞争格局、市场预测（2030 年）

Orthopedic Digit Implants - Market Insights, Competitive Landscape, and Market Forecast - 2030
出版日期: | 出版商: DelveInsight | 英文 150 Pages | 商品交期: 2-10个工作天内

价格

全球骨科手指植入物市场规模预计到2023年将达到9,234万美元，到2030年将达到1,3453万美元，2024-2030年预测期间复合年增长率为6.50%。矫形手指植入物需求的增加主要是由于世界老年人口的不断增长和类风湿性关节炎盛行率的上升。此外，骨科疾病的增加正在推动骨科手指植入物市场的成长。此外，全球对微创手术的需求不断增长，预计将增强市场，并促进 2024-2030 年预测期内骨科手指植入物市场的成长。

矫形手指植入物市场动态

由于各种原因，矫形手指植入物市场的产品需求正在成长。

类风湿性关节炎的盛行率在全球范围内不断增加，预计将增强市场。例如，根据世界卫生组织（WHO）（2022）的数据，预计2020年至2022年全球将有超过2,300万人患有类风湿性关节炎。据同一消息来源称，预计到 2030 年，患有类风湿性关节炎的患者人数将增加一倍。类风湿性关节炎主要攻击关节，导致身体受影响区域发炎和疼痛肿胀。为了治疗这种情况，许多患者使用骨科植入物，这有助于减轻发炎和疼痛。因此，类风湿性关节炎盛行率的增加将增加市场对骨科手指植入物的需求，从而推动该设备在预测期内的整体市场成长。

此外，由于骨科疾病患者数量不断增加，老年患者数量的增加也将增加对骨科手指植入物的需求。例如，根据世界卫生组织（2022）的数据，到2030年，全世界六分之一的人将超过60岁。全球60岁及以上人口比例将从2020年的10亿增加到14亿。到2050年，全球60岁及以上的人口将增加一倍。2020 年至 2050 年间，80 岁及以上的人口预计将增加两倍，达到 4.26 亿人。因此，老年人口的增加影响了膝盖、脚趾、臀部和脚踝等骨科疾病的盛行率。预计骨科疾病盛行率的增加将在预测期内加强骨科手指植入物市场。

然而，严格的监管批准、过敏、植入物错位、术后感染和植入物毒性可能会阻碍骨科手指植入物市场的成长。

持续的 COVID-19 大流行对骨科手指植入物市场产生了轻微影响。疾病爆发之初，由于严格封锁以遏制病毒传播，出现了严重短缺。与 COVID-19 患者相比，类风湿性关节炎和骨科疾病等慢性病患者的住院优先顺序较低。一些医疗器材的生产已停止。此外，在大流行期间，手术暂时停止。为了降低 COVID-19 传播的风险，医生推迟或取消了半紧急和选择性病例。然而，随着越来越多的人接种疫苗以及资源和原材料供应的恢復，骨科手指植入物市场正在恢復势头。

骨科手指植入物市场区隔分析

在矫形手指植入物市场的材料类型领域，预计到 2023 年钛材料将占据矫形手指植入物市场的主要份额。这是由于钛矫形手指植入物具有多种优点。

钛植体最重要的优点是这些植体具有非常高的体内耐腐蚀性，并与骨骼具有出色的生物相容性。虽然其他材料会随着时间的推移而退化并产生小裂纹，但钛克服了这个缺点。

本报告提供了全球整形外科手指植入物市场的研究和分析，包括市场规模和预测、驱动因素和挑战以及公司和产品概况。

目录

第一章 矫形手指植入物市场报告介绍

第二章骨科手指植入物市场执行摘要

  • 调查范围
  • 市场概况
  • 竞争评估
  • 财务基准

第三章 监管分析

  • 美国
  • 欧洲
  • 日本
  • 中国

第四章骨科手指植入物市场关键因素分析

  • 骨科手指植入物市场的驱动因素
    • 世界各地老年人口不断增加
    • 类风湿性关节炎盛行率上升
    • 骨科疾病增加
    • 对治疗骨科疾病的微创手术的需求不断增长
  • 骨科手指植入物市场限制与挑战
    • 严格的监管审批
    • 过敏、植体移位、术后感染及植体毒性
  • 骨科手指植入物市场机会
    • 3D列印技术在骨科领域的快速普及

第五章骨科手指植入物市场的波特五力分析

第六章 COVID-19对骨科手指植入物市场的影响分析

第七章 骨科手指植入物市场布局

  • 按产品类型
    • 跖骨关节植入物
    • 掌指关节植入物
    • 脚趾髓内植入物
    • 舟状指植入物
    • 半指手指植入物
  • 依材料类型
    • 热解碳
    • 钛
    • 尼尼托尔
    • 其他
  • 按最终用户
    • 医院
    • 骨科诊所
  • 按地区
    • 北美
    • 欧洲
    • 亚太地区
    • 其他地区

第八章骨科手指植入物市场：全球公司份额分析－3至5家主要公司

第九章矫形手指植入物市场公司与产品概况

  • Acumed LLC
  • Integra LifeSciences Corporation
  • Smith & Nephew
  • Johnson & Johnson
  • Stryker
  • Arthrex, Inc.
  • VILEX, LLC
  • Merete GmbH
  • Anika Therapeutics, Inc.
  • Advin Health Care
  • Bond Well Ortho Products.
  • Zimmer Biomet.
  • Teijin Nakashima Medical Co., Ltd.
  • Safe Orthopaedics
  • ArthroCare Corporation

第10章 KOL观点

第十一章专案方法

第 12 章. 关于 DelveInsight

第十三章 免责声明与联络资讯

Product Code: DIMDCL0184

Orthopedic Digit Implants Market By Product Type (Meta Tarsal Joint Implants, Meta Carpal Joint Implants, Toe Intramedullary Digit Implants, Scophoid Bone Digit Implants, And Hemiphalangeal Digit Implants), By Material Type (Pyrocarbon, Titanium, Ninitol, And Others), By End-User (Hospitals, Speciality Orthopedic Clinics, And Others), by geography is expected to grow at a healthy CAGR forecast till 2030 owing to increasing geriatric population in the region and rising prevalence of rheumatoid arthritis worldwide

Global orthopedic digit implants market was valued at USD 92.34 Million in 2023, growing at a CAGR of 6.50% during the forecast period from 2024 to 2030 to reach USD 134.53 Million by 2030. The increase in demand for orthopedic digit implants is primarily attributed to the increasing geriatric population worldwide and rising prevalence of rheumatoid arthritis. Additionally, the increasing number of orthopedic conditions will propel the market growth of orthopedic digit implants. Further, the rising demand for minimally invasive operations across the world are anticipated to bolster the market, thereby contributing to the growth of the orthopedic digit implants market during the forecast period from 2024-2030.

Orthopedic Digit Implants Market Dynamics:

The orthopedic digit implants market is witnessing a growth in product demand owing to various reasons.

The rising prevalence of rheumatoid arthritis, across the world are anticipated to bolster the market. For instance, as per the World Health Organization (WHO) 2022, it was estimated that more than 23 million people globally suffered from rheumatoid arthritis in the year 2020 - 2022. As per the same source, it was estimated that by the year 2030, the number of patients suffering from rheumatoid arthritis will get double. Rheumatoid arthritis mainly attacks the joints causing inflammation and painful swelling in the affected parts of the body. To cure this, many patients go for orthopedic implants, which helps in reduction of both inflammation and pain. Thus, the increasing prevalence of rheumatoid arthritis will increase the demand of orthopedic digit implants in the market, thereby propelling the overall market growth of the device in the forecast period.

Additionally, the increasing number of geriatric patients will also increase the demand of the orthopedic digit implants as the geriatric people are more to the orthopedic disorders. For instance, according to WHO 2022, by 2030, one in six people in the world will be aged 60 years or over. The share of the population aged 60 years and over will increase from 1 billion in 2020 to 1.4 billion globally. By 2050, the world's population of people aged 60 years and older will double (2.1 billion). The number of people aged 80 years or older is expected to triple between 2020 and 2050 to reach 426 million. Thus, the number of geriatric population is increasing which will in turn affect the prevalence of orthopedic disorders in knee, toe, hip, ankle, and others as age is one of the major risk factor for these disorders. The increased prevalence of orthopedic disorder will bolster the market of orthopedic digit implants in the forecast period.

However, stringent regulatory approvals and hypersensitivity, displacement of the implant, infections after surgery, and toxicity from the implant may hamper the orthopedic digit implants market growth.

The ongoing COVID-19 pandemic has slightly impacted the market for orthopedic digit implants. At the onset of the disease, there was a significant shortage, attributed to the imposition of stringent lockdowns to curb the spread of the virus. Hospital admissions for patients suffering from rheumatoid arthritis, orthopedic disorders and other chronic disorders were not a priority in comparison to the patients suffering from coronavirus. Production of some forms of medical devices was shut down. Furthermore, surgeries were temporarily stopped during the pandemic. To reduce the COVID-19 transmission risk, the physician have either postponed or canceled the semi-urgent and elective cases. However, with masses being vaccinated and with the resumption of resources and raw materials, the orthopedic digit implants market has picked momentum.

Orthopedic Digit Implants Market Segment Analysis:

Orthopedic Digit Implants Market by Product Type (Meta Tarsal Joint Implants, Meta Carpal Joint Implants, Toe Intramedullary Digit Implants, Scophoid Bone Digit Implants, and Hemiphalangeal Digit Implants), by Material Type (Pyrocarbon, Titanium, Ninitol, and Others), by End User (Hospitals, Speciality Orthopedic Clinics, and Others), and by Geography (North America, Europe, Asia-Pacific, and Rest of the World).

In the material type segment of the orthopedic digit implants market, the titanium segment is estimated to hold a significant share in the orthopedic digit implants market in the year 2023. This can be ascribed to the various advantages that are associated with the titanium orthopedic digit implant.

The most important benefit of titanium implant is that these implants have a very high resistance to corrosion in the body and offer an excellent biocompatibility with the bone. Over time other materials can deteriorate and lead to tiny cracks but titanium overpower this disadvantage.

Moreover, the titanium surface of the implant fuses with the surrounding bone through the Osseo integration process while healing, which can take about 3 to 6 months.

Furthermore, the titanium implants are incredibly strong, have high flexural properties and resist fracture.

Moreover, the product launches, in turn, drive the product demand in the market. For instance, in June 2020, Xenco Medical, surgical implant maker had announced the nationwide launch of the first injection-molded titanium foam spinal implants pre-attached to disposable, composite polymer instruments, the CancelleX porous titanium lumbar interbodies.

Thus, owing to the various advantages offered by the titanium orthopedic digit implants and an increase in the launch and approvals of the device, there will be an increase in the demand for titanium orthopedic digit implant, which in turn will drive the orthopedic digit implants market growth.

North America is expected to dominate the overall Orthopedic Digit Implants Market:

Among all the regions, North America is estimated to achieve a significant share in the global Orthopedic Digit Implants market. Increasing geriatric population in the region and rising prevalence of rheumatoid arthritis will increase the demand for orthopedic digit implants in North America, leading to a rise in the overall orthopedic digit implants market growth. Moreover, the rising awareness and demand of minimally invasive surgeries will bolster the overall market growth in the North America.

According to the Government of Canada 2022, by 2030 seniors are expected to surge over 9.5 million and make up about 23% of the Canadians. Moreover, as per the same source, by 2036, the average life expectancy at birth for women will rise to 86.2 years from the current 84.2 and to 82.9 years from the current 80 for men. Geriatric patients are more prone to orthopedic disorders. As the number of geriatric people is expected to increase in the forecast period a rise in demand of orthopedic digit implants in the market is seen in the forecast period in the region.

Additionally, owing to the region's robust economic position and well-developed healthcare infrastructure, the market of the device will increase in the region in the year 2023 - 2028.

Moreover, the product launch, in the region, in turn will tend to increase the market growth of the device. For instance, in December 2020, Ensemble Orthopedics Inc., a privately held orthopedic company had received 510 (k) approval from the United States Food and Drug Administration for its inclusion of the Ensemble CMC. Ensemble CMC is designed to treat patients with osteoarthritis of the anterior segment of the carpometacarpal joint (CMC) using a minimally invasive, simple surgical procedure.

Furthermore, the rising prevalence of osteoarthritis will increase the product demand in North America. As per the CDC 2020, it was estimated osteoarthritis affected over 32.5 million US adults in the year 2020. As per the same source, it was concluded that women suffer more from osteoarthritis than the men. Osteoarthritis can damage any form of joint, the disorder most commonly affects joints in the hands, knees, hips and spine and causes inflammation and severe pain. To cure the disorder patient go the orthopedic digit implants through a minimally invasive surgical procedure. Therefore increasing the demand in the orthopedic digit implants market. Thus, the increasing prevalence of osteoarthritis in the North America will increase the demand of the orthopedic digit implant thereby anticipated to propel the overall market growth in the North America in the forecast period of 2022 - 2028.

Thus, all the above-mentioned factors are anticipated to propel the market for orthopedic digit implants in the North America.

Orthopedic Digit Implants Market Key Players:

Some of the key market players operating in the Orthopedic Digit Implants market include Acumed LLC, Integra LifeSciences Corporation, Smith & Nephew, Johnson & Johnson, Stryker, Arthrex, Inc., VILEX, LLC, Merete GmbH, Anika Therapeutics, Inc., Advin Health Care, Bond Well Ortho Products., Zimmer Biomet., Teijin Nakashima Medical Co., Ltd., Safe Orthopaedics, ArthroCare Corporation, among others.

Recent Developmental Activities in the Orthopedic Digit Implants Market:

In February 2022, Johnson & Johnson Medical Devices Companies, Medical Devices Companies announced that DePuy Synthes, the Orthopaedics Company of Johnson & Johnson has acquired CrossRoads® Extremity Systems, a Tennessee-based foot and ankle company that provides a broad range of procedure-specific, sterile-packed implants and instrumentation systems cleared for lower extremity indications.

In August 2022, The Johnson & Johnson Medical Devices Companies announced that DePuy Synthes, The Orthopaedics Company of Johnson & Johnson, introduced the INHANCE(TM) Shoulder System. The company stated that the INHANCE Shoulder System is the first shoulder system to offer surgeons the ability to seamlessly transition from stemless to stemmed implants during surgical procedures.

In November 2020, DJO, LLC, a leading global provider of medical technologies to get and keep people moving, announced that it has completed the acquisition of total ankle and finger arthroplasty product lines from international medical technology company Stryker.

In November 2020, Stryker, one of the world's leading medical technology companies, announced that it has completed the previously announced acquisition of Wright Medical Group N.V., a global medical device company focused on extremities and biologics.

Key Takeaways from the Orthopedic Digit Implants Market Report Study

  • Market size analysis for current orthopedic digit implants market size (2023), and market forecast for 5 years (2024-2030)
  • The effect of the COVID-19 pandemic on this market is significant. To capture and analyze suitable indicators, our experts are closely watching the orthopedic digit implants market.
  • Top key product/services/technology developments, merger, acquisition, partnership, joint venture happened for last 3 years
  • Key companies dominating the global orthopedic digit implants market.
  • Various opportunities available for the other competitor in the orthopedic digit implants market space.
  • What are the top performing segments in 2023? How these segments will perform in 2030.
  • Which is the top-performing regions and countries in the current orthopedic digit implants market scenario?
  • Which are the regions and countries where companies should have concentrated on opportunities for orthopedic digit implants market growth in the coming future?

Target Audience who can be benefited from this Orthopedic Digit Implants Market Report Study

  • Orthopedic digit implants products providers
  • Research organizations and consulting companies
  • Orthopedic digit implants-related organizations, associations, forums, and other alliances
  • Government and corporate offices
  • Start-up companies, venture capitalists, and private equity firms
  • Distributors and Traders dealing in orthopedic digit implants
  • Various End-users who want to know more about the orthopedic digit implants market and latest technological developments in the orthopedic digit implants market.

Frequently Asked Questions for Orthopedic Digit Implants Market:

1. What are Orthopedic Digit Implants?

An orthopedic digit implants, are the medical devices, that are used to replace damaged or injured small bone or join segments such as toe, elbow, ankle, knee, and others. The orthopedic digits are biocompatible and made up of titanium or stainless steel, and they function as artificial bones.

2. What is the market for Global Orthopedic Digit Implants?

Global orthopedic digit implants market was valued at USD 92.34 Million in 2023, growing at a CAGR of 6.50% during the forecast period from 2024 to 2030 to reach USD 134.53 Million by 2030.

3. What are the drivers for the Global Orthopedic Digit Implants Market?

The orthopedic digit implants market is witnessing a positive market growth owing to the increasing geriatric population worldwide and rising prevalence of rheumatoid arthritis. Additionally, the increasing number of orthopedic conditions will propel the market growth of orthopaedic digit implants. Further, the rising demand for minimally invasive operations to treat orthopedic disease across the world are anticipated to bolster the market.

4. Who are the key players operating in the Global Orthopedic Digit Implants Market?

Some of the key market players operating in the orthopedic digit implants market include Acumed LLC, Integra LifeSciences Corporation, Smith & Nephew, Johnson & Johnson, Stryker, Arthrex, Inc., VILEX, LLC, Merete GmbH, Anika Therapeutics, Inc., Advin Health Care, Bond Well Ortho Products., Zimmer Biomet., Teijin Nakashima Medical Co., Ltd., Safe Orthopaedics, ArthroCare Corporation, and others.

5. Which region has the highest share in Orthopedic Digit Implants Market?

North America is expected to hold the highest share in the revenue in the orthopedic digit implants market during the forecast period. Increasing geriatric population in the region and rising prevalence of rheumatoid arthritis will increase the demand for orthopedic digit implants in North America, leading to a rise in the overall orthopedic digit implants market growth in this region.

Table of Contents

1.Orthopedic Digit Implants Market Report Introduction

2.Orthopedic Digit Implants Market Executive Summary

  • 2.1. Scope of the Study
  • 2.2. Market at Glance
  • 2.3. Competitive Assessment
  • 2.4. Financial Benchmarking

3. Regulatory Analysis

  • 3.1. The United States
  • 3.2. Europe
  • 3.3. Japan
  • 3.4. China

4. Orthopedic Digit Implants Market Key Factors Analysis

  • 4.1. Orthopedic Digit Implants Market Drivers
    • 4.1.1. Increasing geriatric population worldwide
    • 4.1.2. Rising prevalence of rheumatoid arthritis
    • 4.1.3. Increasing number of orthopedic conditions
    • 4.1.4. Rising demand for minimally invasive operations to treat orthopedic disease
  • 4.2. Orthopedic Digit Implants Market Restraints and Challenges
    • 4.2.1. Stringent regulatory approvals
    • 4.2.2. Hypersensitivity, displacement of the implant, infections after surgery, and toxicity from the implant
  • 4.3. Orthopedic Digit Implants Market Opportunities
    • 4.3.1. Rapid penetration of 3D printing technology in orthopedics

5. Orthopedic Digit Implants Market Porter's Five Forces Analysis

  • 5.1. Bargaining Power of Suppliers
  • 5.2. Bargaining Power of Consumers
  • 5.3. Threat of New Entrants
  • 5.4. Threat of Substitutes
  • 5.5. Competitive Rivalry

6. COVID-19 Impact Analysis on Orthopedic Digit Implants Market

7. Orthopedic Digit Implants Market Layout

  • 7.1. By Product Type
    • 7.1.1. Meta Tarsal Joint Implants
    • 7.1.2. Meta Carpal Joint Implants
    • 7.1.3. Toe Intramedullary Digit Implants
    • 7.1.4. Scaphoid Bone Digit Implants
    • 7.1.5. Hemiphalangeal Digit Implants
  • 7.2. By Material Type
    • 7.2.1. Pyrocarbon
    • 7.2.2. Titanium
    • 7.2.3. Ninitol
    • 7.2.4. Others
  • 7.3. By End User
    • 7.3.1. Hospitals
    • 7.3.2. Specialty Orthopedic Clinics
    • 7.3.3. Others
  • 7.4. By Geography
    • 7.4.1. North America
      • 7.4.1.1. North America Orthopedic Digit Implants Market, by Country
      • 7.4.1.1.1. United States
      • 7.4.1.1.2. Canada
      • 7.4.1.1.3. Mexico
    • 7.4.2. Europe
      • 7.4.2.1. Europe Orthopedic Digit Implants Market, by Country
      • 7.4.2.1.1. France
      • 7.4.2.1.2. Germany
      • 7.4.2.1.3. United Kingdom
      • 7.4.2.1.4. Italy
      • 7.4.2.1.5. Spain
      • 7.4.2.1.6. Russia
      • 7.4.2.1.7. Rest of Europe
    • 7.4.3. Asia-Pacific
      • 7.4.3.1. Asia-Pacific Orthopedic Digit Implants Market, by Country
      • 7.4.3.1.1. China
      • 7.4.3.1.2. Japan
      • 7.4.3.1.3. India
      • 7.4.3.1.4. Australia
      • 7.4.3.1.5. South Korea
      • 7.4.3.1.6. Rest of Asia Pacific
    • 7.4.4. Rest of the World (RoW)
      • 7.4.4.1. RoW Orthopedic Digit Implants Market, by Region
      • 7.4.4.1.1. Middle East
      • 7.4.4.1.2. Africa
      • 7.4.4.1.3. South America

8. Orthopedic Digit Implants Market Global Company Share Analysis - Key 3-5 Companies

9. Orthopedic Digit Implants Market Company and Product Profiles

  • 9.1. Acumed LLC
    • 9.1.1. Company Overview
    • 9.1.2. Company Snapshot
    • 9.1.3. Financial Overview
    • 9.1.4. Product Listing
    • 9.1.5. Entropy
  • 9.2. Integra LifeSciences Corporation
    • 9.2.1. Company Overview
    • 9.2.2. Company Snapshot
    • 9.2.3. Financial Overview
    • 9.2.4. Product Listing
    • 9.2.5. Entropy
  • 9.3. Smith & Nephew
    • 9.3.1. Company Overview
    • 9.3.2. Company Snapshot
    • 9.3.3. Financial Overview
    • 9.3.4. Product Listing
    • 9.3.5. Entropy
  • 9.4. Johnson & Johnson
    • 9.4.1. Company Overview
    • 9.4.2. Company Snapshot
    • 9.4.3. Financial Overview
    • 9.4.4. Product Listing
    • 9.4.5. Entropy
  • 9.5. Stryker
    • 9.5.1. Company Overview
    • 9.5.2. Company Snapshot
    • 9.5.3. Financial Overview
    • 9.5.4. Product Listing
    • 9.5.5. Entropy
  • 9.6. Arthrex, Inc.
    • 9.6.1. Company Overview
    • 9.6.2. Company Snapshot
    • 9.6.3. Financial Overview
    • 9.6.4. Product Listing
    • 9.6.5. Entropy
  • 9.7. VILEX, LLC
    • 9.7.1. Company Overview
    • 9.7.2. Company Snapshot
    • 9.7.3. Financial Overview
    • 9.7.4. Product Listing
    • 9.7.5. Entropy
  • 9.8. Merete GmbH
    • 9.8.1. Company Overview
    • 9.8.2. Company Snapshot
    • 9.8.3. Financial Overview
    • 9.8.4. Product Listing
    • 9.8.5. Entropy
  • 9.9. Anika Therapeutics, Inc.
    • 9.9.1. Company Overview
    • 9.9.2. Company Snapshot
    • 9.9.3. Financial Overview
    • 9.9.4. Product Listing
    • 9.9.5. Entropy
  • 9.10. Advin Health Care
    • 9.10.1. Company Overview
    • 9.10.2. Company Snapshot
    • 9.10.3. Financial Overview
    • 9.10.4. Product Listing
    • 9.10.5. Entropy
  • 9.11. Bond Well Ortho Products.
    • 9.11.1. Company Overview
    • 9.11.2. Company Snapshot
    • 9.11.3. Financial Overview
    • 9.11.4. Product Listing
    • 9.11.5. Entropy
  • 9.12. Zimmer Biomet.
    • 9.12.1. Company Overview
    • 9.12.2. Company Snapshot
    • 9.12.3. Financial Overview
    • 9.12.4. Product Listing
    • 9.12.5. Entropy
  • 9.13. Teijin Nakashima Medical Co., Ltd.
    • 9.13.1. Company Overview
    • 9.13.2. Company Snapshot
    • 9.13.3. Financial Overview
    • 9.13.4. Product Listing
    • 9.13.5. Entropy
  • 9.14. Safe Orthopaedics
    • 9.14.1. Company Overview
    • 9.14.2. Company Snapshot
    • 9.14.3. Financial Overview
    • 9.14.4. Product Listing
    • 9.14.5. Entropy
  • 9.15. ArthroCare Corporation
    • 9.15.1. Company Overview
    • 9.15.2. Company Snapshot
    • 9.15.3. Financial Overview
    • 9.15.4. Product Listing
    • 9.15.5. Entropy

10. KOL Views

11. Project Approach

12. About DelveInsight

13. Disclaimer & Contact Us

List of Tables

  • Table 1: Competitive Analysis
  • Table 2: COVID-19 Impact Analysis
  • Table 3: Orthopedic Digit Implants Market in Global (2021-2030)
  • Table 4: Orthopedic Digit Implants Market in Global by Product Type (2021-2030)
  • Table 5: Orthopedic Digit Implants Market in Global by Material Type (2021-2030)
  • Table 6: Orthopedic Digit Implants Market in Global by End User (2021-2030)
  • Table 7: Orthopedic Digit Implants Market in Global by Geography (2021-2030)
  • Table 8: Orthopedic Digit Implants Market in North America (2021-2030)
  • Table 9: Orthopedic Digit Implants Market in North America by Country (2021-2030)
  • Table 10: Orthopedic Digit Implants Market in the US (2021-2030)
  • Table 11: Orthopedic Digit Implants Market in Canada (2021-2030)
  • Table 12: Orthopedic Digit Implants Market in Mexico (2021-2030)
  • Table 13: Orthopedic Digit Implants Market in Europe (2021-2030)
  • Table 14: Orthopedic Digit Implants Market in Europe by Country (2021-2030)
  • Table 16: Orthopedic Digit Implants Market in France (2021-2030)
  • Table 17: Orthopedic Digit Implants Market in Germany (2021-2030)
  • Table 18: Orthopedic Digit Implants Market in the United Kingdom (2021-2030)
  • Table 19: Orthopedic Digit Implants Market in Italy (2021-2030)
  • Table 20: Orthopedic Digit Implants Market in Spain (2021-2030)
  • Table 21: Orthopedic Digit Implants Market in Russia (2021-2030)
  • Table 22: Orthopedic Digit Implants Market in Rest of Europe (2021-2030)
  • Table 23: Orthopedic Digit Implants Market in APAC (2021-2030)
  • Table 24: Orthopedic Digit Implants Market in APAC by Country (2021-2030)
  • Table 25: Orthopedic Digit Implants Market in China (2021-2030)
  • Table 26: Orthopedic Digit Implants Market in Japan (2021-2030)
  • Table 27: Orthopedic Digit Implants Market in India (2021-2030)
  • Table 28: Orthopedic Digit Implants Market in Australia (2021-2030)
  • Table 29: Orthopedic Digit Implants Market in South Korea (2021-2030)
  • Table 30: Orthopedic Digit Implants Market in Rest of APAC (2021-2030)
  • Table 31: Orthopedic Digit Implants Market in Rest of World (2021-2030)
  • Table 32: Orthopedic Digit Implants Market in RoW by Region (2021-2030)
  • Table 33: Orthopedic Digit Implants Market in Middle East (2021-2030)
  • Table 34: Orthopedic Digit Implants Market in Africa (2021-2030)
  • Table 35: Orthopedic Digit Implants Market in South America (2021-2030)

List of Figures

  • Figure 1: Competitive Analysis
  • Figure 2: COVID-19 Impact Analysis
  • Figure 3: Orthopedic Digit Implants Market in Global (2021-2030)
  • Figure 4: Orthopedic Digit Implants Market in Global by Product Type (2021-2030)
  • Figure 4: Orthopedic Digit Implants Market in Global by Material Type (2021-2030)
  • Figure 5: Orthopedic Digit Implants Market in Global by End User (2021-2030)
  • Figure 6: Orthopedic Digit Implants Market in Global by Geography (2021-2030)
  • Figure 7: Orthopedic Digit Implants Market in North America (2021-2030)
  • Figure 8: Orthopedic Digit Implants Market in North America by Country (2021-2030)
  • Figure 9: Orthopedic Digit Implants Market in the US (2021-2030)
  • Figure 10: Orthopedic Digit Implants Market in Canada (2021-2030)
  • Figure 11: Orthopedic Digit Implants Market in Mexico (2021-2030)
  • Figure 12: Orthopedic Digit Implants Market in Europe(2021-2030)
  • Figure 13: Orthopedic Digit Implants Market in Europe by Country (2021-2030)
  • Figure 14: Orthopedic Digit Implants Market in France (2021-2030)
  • Figure 15: Orthopedic Digit Implants Market in Germany (2021-2030)
  • Figure 16: Orthopedic Digit Implants Market in the United Kingdom (2021-2030)
  • Figure 17: Orthopedic Digit Implants Market in Italy (2021-2030)
  • Figure 18: Orthopedic Digit Implants Market in Spain (2021-2030)
  • Figure 19: Orthopedic Digit Implants Market in Russia (2021-2030)
  • Figure 20: Orthopedic Digit Implants Market in Rest of Europe (2021-2030)
  • Figure 21: Orthopedic Digit Implants Market in APAC (2021-2030)
  • Figure 22: Orthopedic Digit Implants Market in APAC by Country (2021-2030)
  • Figure 23: Orthopedic Digit Implants Market in China (2021-2030)
  • Figure 24: Orthopedic Digit Implants Market in Japan (2021-2030)
  • Figure 25: Orthopedic Digit Implants Market in India (2021-2030)
  • Figure 26: Orthopedic Digit Implants Market in Australia (2021-2030)
  • Figure 27: Orthopedic Digit Implants Market in South Korea (2021-2030)
  • Figure 28: Orthopedic Digit Implants Market in Rest of APAC (2021-2030)
  • Figure 29: Orthopedic Digit Implants Market in Rest of World (2021-2030)
  • Figure 30: Orthopedic Digit Implants Market in RoW by Region (2021-2030)
  • Figure 31: Orthopedic Digit Implants Market in Middle East (2021-2030)
  • Figure 32: Orthopedic Digit Implants Market in Africa (2021-2030)
  • Figure 33: Orthopedic Digit Implants Market in South America (2021-2030)
  • Figure 34: Market Drivers
  • Figure 35: Market Barriers
  • Figure 36: Marker Opportunities
  • Figure 37: PORTER'S Five Force Analysis